Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,653Revenue (TTM) $M97.5Net Margin (%)--Altman Z-Score--
Enterprise Value $M--EPS (TTM) $-0.2Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M147ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with DYAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DYAXMario Gabelli 2016-03-31 Sold Out -0.05%$37.61 - $38.41
($37.98)
$ 38.411%Sold Out0
DYAXKen Fisher 2016-03-31 Sold Out -0.01%$37.61 - $38.41
($37.98)
$ 38.411%Sold Out0
DYAXMario Gabelli 2015-12-31 Buy 0.05%$19.78 - $37.74
($32.46)
$ 38.4118%New holding187,150
DYAXKen Fisher 2015-09-30 Add$17.68 - $28.34
($23.88)
$ 38.4161%Add 1.60%185,375
DYAXKen Fisher 2015-03-31 Buy 0.01%$13.55 - $17.54
($15.57)
$ 38.41147%New holding182,450
DYAXJoel Greenblatt 2015-03-31 Sold Out -0.006%$13.55 - $17.54
($15.57)
$ 38.41147%Sold Out0
DYAXJoel Greenblatt 2014-06-30 Buy 0.01%$6.11 - $9.96
($7.59)
$ 38.41406%New holding46,505
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DYAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DYAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KEMPNER THOMAS LDirector 2015-09-10Sell6,000$22.4770.94view
KEMPNER THOMAS LDirector 2015-08-28Sell17,947$23.8361.18view
KEMPNER THOMAS LDirector 2015-08-18Sell18,035$23.8361.18view
MIGAUSKY GEORGE VEVP & CFO 2015-08-17Sell125,000$22.8568.1view
KEMPNER THOMAS LDirector 2015-08-13Sell4,848$23.8161.32view
KEMPNER THOMAS LDirector 2015-08-11Sell120,800$23.8161.32view
Christensen GustavCEO and President 2015-08-05Sell250,000$23.8660.98view
Bazemore ToddEVP & Chief Commercial Officer 2015-08-05Sell43,000$23.6262.62view
KEMPNER THOMAS LDirector 2015-08-04Sell7,000$24.2458.46view
Ashe Andrew D.General Counsel & EVP 2015-08-03Sell62,320$24.2158.65view

Quarterly/Annual Reports about DYAX:

News about DYAX:

Articles On GuruFocus.com
Mario Gabelli Comments on Dyax Corp May 03 2016 
The Gabelli ABC Fund 1st Quarter Shareholder Commentary May 03 2016 
Meridian Funds Comments on Dyax Corp Mar 07 2016 
Meridian Growth Fund Semi-Annual Letter to Shareholders Mar 07 2016 
Mario Gabelli Comments on Dyax Corp Jan 29 2016 
Chuck Royce Makes Big Gains on Divestitures Jan 03 2016 
Voltari Corp. (VLTC) Under Carl Icahn Umbrella, Dyax Corp. (DYAX) Potential Angioedema Preventive Tr Apr 01 2015 
Weekly CFO Buys Highlight: DYAX, IBI, FARM, TAP, DBM Mar 19 2011 
Dyax Corp. (DYAX) CEO Gustav Christensen buys 10,000 Shares Mar 15 2011 
Dyax Corp. (DYAX) CEO Gustav Christensen buys 10,000 Shares Mar 15 2011 

More From Other Websites
Peter Kolchinsky Is Betting Big On Achillion Pharmaceuticals, Inc. (ACHN), Wave Life Sciences (WVE)... Feb 25 2016
Here Are The Most Notable Insider Transactions Hitting The Market Jan 26 2016
Shire stays mum on Burlington facilities, employees in wake of Dyax acquisition Jan 25 2016
DYAX CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of... Jan 22 2016
Shire Completes Acquisition of Dyax Jan 22 2016
Shire Completes Acquisition of Dyax Jan 22 2016
Technical Scrutiny on Biotechnology Stocks -- Gilead Sciences, Sarepta Therapeutics, Dyax Corp., and... Jan 21 2016
3 Stocks Making New 52-Week Highs Jan 20 2016
The Zacks Analyst Blog Highlights: ALPS Medical Breakthroughs ETF, Anacor Pharmaceuticals, Dyax,... Dec 29 2015
5 Top Performing Stocks of the Top ETF of 2015 Dec 28 2015
Here are the 20 top-performing stocks in Mass. for 2015 Dec 14 2015
DYAX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 11 2015
Dyax Corp. Sets January 21, 2016 As Date of Special Stockholder Meeting To Vote On Its Proposed... Dec 11 2015
Dyax Corp. Sets January 21, 2016 As Date of Special Stockholder Meeting To Vote On Its Proposed... Dec 11 2015
DYAX CORP Financials Dec 08 2015
Dyax Corp. Presents Phase 1b DX-2930 Data at the American College of Allergy, Asthma, and Immunology... Dec 08 2015
Dyax Corp. Presents DX-4012 Data at the 2015 American Society of Hematology Annual Meeting Dec 08 2015
Dyax Corp. Announces Early Termination of Hart-Scott-Rodino Waiting Period Dec 08 2015
Dyax Corp. Recognized as a "Top Place to Work" by The Boston Globe for Second Year in a Row Dec 08 2015
Dyax Corp. Presents DX-4012 Data at the 2015 American Society of Hematology Annual Meeting Dec 06 2015
The SPDR S&P Biotech ETF Lingers in the Red as of December 3 Dec 04 2015
Strength Seen in Dyax Corp (DYAX): Stock Rises 12.2% Dec 04 2015
DYAX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 02 2015
Dyax Corp. Announces Early Termination of Hart-Scott-Rodino Waiting Period Dec 02 2015
Do Hedge Funds Love Dyax Corp. (DYAX)? Dec 01 2015
Is Vista Outdoor Inc (VSTO) A Good Stock To Buy? Nov 24 2015
Shire buys US biotech firm Dyax for $5.9bn: companies Nov 02 2015
Dyax Corp. Announces Third Quarter 2015 Financial Results Oct 28 2015
Dyax Corp. to Review Third Quarter 2015 Financial Results at Research and Development Day Oct 27 2015
Dyax Corp. to Webcast 2015 Research and Development Day Oct 26 2015
Dyax Corp. to Host Third Quarter 2015 Financial Results Call and Webcast Oct 14 2015
Dyax Corp. Receives Positive Opinion for Orphan Medicinal Product Designation in the European Union... Sep 30 2015
Dyax Corp. to Participate in the Leerink Partners 4th Annual Rare Disease Roundtable Sep 22 2015
Dyax Corp. to Participate in the Morgan Stanley Global Healthcare Conference Sep 02 2015
Dyax Corp. Provides Update on DX-2930 Clinical and Commercial Supply Initiatives Aug 12 2015
Dyax Corp. to Participate in the 2015 Wedbush PacGrow Healthcare Conference Aug 06 2015
Dyax Corp. Announces Second Quarter 2015 Financial Results Jul 29 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)